BerGenBio

BerGenBio ASA: Notice of extraordinary general meeting

Bergen, Norway, 16 February 2018 - On 9 March 2018 at 11:00 hours (CET) an

extraordinary general meeting of BerGenBio ASA will be held in the Company's

offices in Jonas Lies vei 91, 5009 Bergen.

The notice, registration form and power of attorney are attached to this

release. The notice will be sent to all registered shareholders.

For further information, please contact:

-End-

Contacts

Richard Godfrey

CEO, BerGenBio ASA

+47 917 86 304

Tom Henrik Sundby

Finance Director, BerGenBio ASA

+47 477 54 415

Forward looking statements

This announcement may contain forward-looking statements, which as such are not

historical facts, but are based upon various assumptions, many of which are

based, in turn, upon further assumptions. These assumptions are inherently

subject to significant known and unknown risks, uncertainties and other

important factors. Such risks, uncertainties, contingencies and other important

factors could cause actual events to differ materially from the expectations

expressed or implied in this announcement by such forward-looking statements

This information is subject to the disclosure requirements pursuant to section 5

-12 of the Norwegian Securities Trading Act.

AI Terminal